Grace Therapeutics (GRCE): 10% owner bought ~$8K

~$8K

Approx. value · 4,256 sh @ $1.88

2.95M

Holds after · shares reported

Traded

Oct 19, 2026

Filed

Oct 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 8, 2026Insider · First insider buy since Sep 202310% owner purchased ~$20K of GRCE shares in the open market
2. Sep 9, 2026Insider · 2 peopleInsiders: 2 purchases (~$226K)
3. Sep 21, 2026Insider10% owner purchased ~$21K of GRCE shares in the open market
4. Sep 23, 2026Insider10% owner purchased ~$11K of GRCE shares in the open market
5. Sep 29, 2026Insider10% owner purchased ~$16K of GRCE shares in the open market
6. Oct 1, 2026Insider10% owner purchased ~$79K of GRCE shares in the open market
7. Oct 2, 2026Insider10% owner purchased ~$41K of GRCE shares in the open market
8. Oct 5, 2026Insider10% owner purchased ~$3.5K of GRCE shares in the open market
9. Oct 8, 2026Insider10% owner purchased ~$4.2K of GRCE shares in the open market
10. Oct 9, 2026Insider10% owner purchased ~$11K of GRCE shares in the open market
11. Oct 12, 2026Insider10% owner purchased ~$15K of GRCE shares in the open market
12. Oct 14, 2026Insider10% owner purchased ~$22K of GRCE shares in the open market
13. Oct 15, 2026Insider10% owner purchased ~$46K of GRCE shares in the open market
14. Oct 16, 2026Insider10% owner purchased ~$69K of GRCE shares in the open market
15. Oct 19, 2026 · this disclosureInsider10% owner purchased ~$8K of GRCE shares in the open market

What came next

1. Oct 22, 2026Insider10% owner purchased ~$41K of GRCE shares in the open market
2. Oct 26, 2026Insider10% owner purchased ~$117K of GRCE shares in the open market
3. Nov 3, 2026Insider · 9 days before results10% owner purchased ~$18K of GRCE shares in the open market
4. Nov 4, 2026Insider · 8 days before results10% owner purchased ~$9.1K of GRCE shares in the open market
5. Nov 5, 2026Insider · 7 days before results10% owner purchased ~$5.5K of GRCE shares in the open market
6. Nov 12, 2026Company filing · Form 8-K · ResultsReported its results
7. Nov 13, 20265% stakeNantahala Capital Management, LLC reported a passive stake (13G) of 7.5%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Grace Therapeutics

For Grace Therapeutics, OQRO holds 21 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GRCE page.

Other recent filings by Opaleye Management Inc., 10% owner

• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Oct 26, 2026
• SEC Form 4 at Alpha Cognition (ACOG)Oct 26, 2026

The full history of Opaleye Management Inc., 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Grace Therapeutics

• SEC Form 4Nov 6, 2026
• SEC Form 4Nov 6, 2026
• SEC Form 4Nov 6, 2026
• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 17, 2026

Everything OQRO holds on this company is on its GRCE page.